Insider Buying: Cosmos Health (NASDAQ:COSM) CEO Purchases $45,873.87 in Stock

Cosmos Health Inc. (NASDAQ:COSM) CEO Grigorios Siokas acquired 218,447 shares of the stock in a transaction dated Thursday, June 11th. The stock was bought at an average price of $0.21 per share, for a total transaction of $45,873.87. Following the purchase, the chief executive officer owned 13,481,808 shares of the company’s stock, valued at $2,831,179.68. The trade was a 1.65% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.

Grigorios Siokas also recently made the following trade(s):

• On Wednesday, June 10th, Grigorios Siokas acquired 701,447 shares of Cosmos Health stock. The stock was bought at an average price of $0.23 per share, for a total transaction of $161,332.81.

Cosmos Health Stock Performance

Shares of Cosmos Health stock opened at $0.21 on Monday. The company’s fifty day simple moving average is $0.30 and its 200-day simple moving average is $0.40. The company has a market cap of $13.04 million, a price-to-earnings ratio of -0.33 and a beta of 4.80. The company has a current ratio of 1.08, a quick ratio of 0.92 and a debt-to-equity ratio of 0.31. Cosmos Health Inc. has a 1 year low of $0.20 and a 1 year high of $1.32.

Cosmos Health (NASDAQ:COSM) last announced its quarterly earnings data on Thursday, May 21st. The company reported ($0.06) earnings per share (EPS) for the quarter, hitting the consensus estimate of ($0.06). The business had revenue of $18.40 million for the quarter, compared to the consensus estimate of $17.93 million. Cosmos Health had a negative net margin of 30.41% and a negative return on equity of 52.85%. As a group, sell-side analysts expect that Cosmos Health Inc. will post -0.06 EPS for the current year.

Institutional Investors Weigh In On Cosmos Health

A number of institutional investors have recently bought and sold shares of the business. Renaissance Technologies LLC boosted its stake in Cosmos Health by 16.7% during the first quarter. Renaissance Technologies LLC now owns 390,500 shares of the company’s stock worth $124,000 after buying an additional 55,925 shares in the last quarter. Citadel Advisors LLC boosted its stake in Cosmos Health by 133.1% during the third quarter. Citadel Advisors LLC now owns 225,507 shares of the company’s stock worth $250,000 after buying an additional 128,776 shares in the last quarter. Finally, XTX Topco Ltd boosted its stake in Cosmos Health by 52.1% during the fourth quarter. XTX Topco Ltd now owns 99,610 shares of the company’s stock worth $50,000 after buying an additional 34,117 shares in the last quarter. Institutional investors and hedge funds own 12.61% of the company’s stock.

Cosmos Health News Summary

Here are the key news stories impacting Cosmos Health this week:

• Positive Sentiment: The company reported annualized sales above $1.5 million for its C-Scrub and C-Sept antiseptic brands in the UK and Greece, and outlined EU expansion plans that could target $7.4 million in revenue and $5.3 million in gross profit by 2028. Article Title
• Positive Sentiment: Cosmos Health announced new contract manufacturing orders totaling 253,657 units, adding to evidence that its Cana subsidiary is seeing steady commercial demand across multiple medicines and pharmaceutical products. Article Title
• Positive Sentiment: CEO Grigorios Siokas made additional open-market share purchases, which investors often view as a signal of management confidence in the company’s outlook. Article Title
• Positive Sentiment: The company signed a letter of intent to acquire Doc Pharma S.A., a GMP manufacturer, a move that could expand assets, production capacity, margins, and its product portfolio if completed. Article Title

About Cosmos Health

Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.